Approximately one-third of human immunodeficiency virus (HIV) 
Introduction
As long ago as 1989, family planning was identified by the International Planned Parenthood Federation (IPPF) as having an important role to play in the control of human immunodeficiency virus (HIV). 1 Currently in the UK approximately one-third of HIV infections remain undiagnosed, 2 with more than half the newly diagnosed cases being acquired through heterosexual sexual intercourse. 3 The National Strategy for Sexual Health and HIV includes as an aim 'the reduction of the proportion of undiagnosed cases of HIV infection'. 4 Late diagnosis of HIV is associated with greater morbidity and mortality, and denies opportunities for targeted safer sex discussion. The introduction of HIV testing as a routine part of antenatal care is helping to identify some of the undiagnosed cases, resulting in fewer cases of vertical transmission of HIV infection. 5 Family planning clinics (FPCs) and 'one-stop' sexual health clinics see clients requesting contraception and preconceptual advice, as do primary care services. The prevalence of HIV among FPC attenders may be low. 6 However, contraceptive services are well placed to extend discussion about HIV testing to their clients, the majority of whom are in favour of this initiative. 7 This is not necessarily easy in busy clinics when seeing clients whose primary reason for attendance is for contraception. The Eastbourne Sexual Health Clinic is a 'one-stop' sexual health clinic combining family planning and genitourinary medicine. 8 The cases of two women who presented for non-barrier methods of contraception and were later diagnosed HIVpositive are presented below. Experience of managing these cases 'under one roof' has raised awareness of the need to offer HIV testing to clients at high risk of HIV infection who attend for contraception.
Case reports
Case 1 A woman from a sub-Saharan country presented for removal of a Norplant, which had been inserted 6 years previously. She reported that her husband had died and that she was not in a sexual relationship. An uneventful removal took place and cervical cytology was discussed.
Two weeks later, she was admitted to hospital with breathlessness and was diagnosed with miliary tuberculosis with involvement of lungs, pleura and cerebrospinal fluid. She was HIV-positive with a CD4 count of 6/mm 3 (6%) and a viral load or 439 662 copies/ml. Cervical cytology performed 1 month after discharge from hospital showed severe dyskaryosis which was treated in a colposcopy clinic.
She has made a good recovery and is, after 16 months on highly active antiretroviral therapy, asymptomatic with a CD4 count of 163/mm 3 (19%) and an undetectable viral load. She continues to visit the sexual health clinic and is discussing the possibility of a new sexual relationship and safer sex.
Case 2
A woman from a sub-Saharan country presented for contraception as she was starting a new sexual relationship. She was given an injection of Depo Provera, which she continued to have regularly for the next year. She reported some postcoital bleeding in the first few weeks, which had settled by the time of her second injection. She was also treated for an episode of bacterial vaginosis during this time.
Eleven months after her first presentation to the clinic she was admitted to hospital with a tuberculous pleural effusion, which responded well to treatment. She subsequently tested positive for HIV with a CD4 count of 110/mm 3 (18%) and a viral load of 248 000/ml. It is planned that she will start highly active antiretroviral therapy in the near future.
Jones admission to hospital with tuberculosis. Both had identifiable risk factors for HIV, which were known at the time of their consultations for contraception. The clinic has revised its approach to HIV testing and now offers this service to all clients with an identified risk factor, regardless of the primary reason for attendance. One of the major risk factors in clients attending for contraception is unprotected sexual intercourse in a country with high HIV prevalence.
This approach seems feasible not only in one-stop sexual health clinics but also in dedicated FPCs, and in general practice where large numbers of clients requesting non-barrier methods of contraception are seen. Clients with a history of unprotected sexual intercourse from countries with high HIV prevalence should be identified, HIV testing discussed, with onward referral where necessary. Condoms should be provided.
Introduction
Tubal occlusion remains the most cost-effective and convenient choice for many parous women seeking contraception, in spite of the increasing availability of reversible methods. Although the reversibility is not an idea that is encouraged at the time of sterilisation, up to 14% 1 of these women regret the decision and request reversal of the procedure. This is a review of our experience at the Glasgow Royal Infirmary, Glasgow, UK with regard to reversal of sterilisation during a 5-year period from 1994 to 1998. During this period, an average of 280 sterilisations and 17 reversals per year had been carried out in this hospital. The objectives were to obtain a profile of women requesting reversal of sterilisation, and to evaluate the procedure itself in terms of safety and restoration of fertility, although the numbers were relatively small and the conclusions tentative in this regard.
Methods
A list of all patients who underwent reversal of sterilisation between 1994 and 1998 was obtained from theatre logbooks at the Glasgow Royal Infirmary. The case records of all these women were used to procure relevant data on the details of the request, work-up and procedure. A follow-up after reversal from the date of surgery until 2000 using case records from the Glasgow Royal Maternity Hospital, which
